Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Primary ovarian malignant melanoma: A systematic review of cases and pooled analysis.

Gynecologic oncology·2026
Same author

Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours.

British journal of cancer·2026
Same author

Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Comparison of efficacy and toxicity of 2 dactinomycin (ACTD) regimens in the second-line treatment of low-risk gestational trophoblastic neoplasia: a retrospective study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

How to design a ROCI (Response Over Continuous Intervention) randomised trial: guidance and a case study.

BMC medical research methodology·2026
Same author

Primary Uterine Nongestational Placental Site Trophoblastic Tumor as a Distinct Entity: A Report of 5 Cases.

The American journal of surgical pathology·2026

関連する実験動画

Updated: Jun 10, 2026

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay
10:28

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay

Published on: January 8, 2012

妊娠中のトロホブラスティック疾患

Michael J Seckl1, Neil J Sebire, Ross S Berkowitz

  • 1Department of Cancer Medicine, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London, UK. m.seckl@imperial.ac.uk

Lancet (London, England)
|August 3, 2010
PubMed
まとめ
この要約は機械生成です。

妊娠期トロフォブラスティック疾患 (GTD) の管理は著しく進歩し,悪性形態の治癒率は98%を超えました. 効果的な治療法,バイオマーカーの使用,集中ケアにより,これらの珍しい腫瘍を患っている女性の治療結果は劇的に改善されています.

さらに関連する動画

Derivation of Mouse Trophoblast Stem Cells from Blastocysts
10:19

Derivation of Mouse Trophoblast Stem Cells from Blastocysts

Published on: June 8, 2010

関連する実験動画

Last Updated: Jun 10, 2026

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay
10:28

Isolation of Primary Mouse Trophoblast Cells and Trophoblast Invasion Assay

Published on: January 8, 2012

Derivation of Mouse Trophoblast Stem Cells from Blastocysts
10:19

Derivation of Mouse Trophoblast Stem Cells from Blastocysts

Published on: June 8, 2010

科学分野:

  • 婦人科 婦人科について
  • 腫瘍学 腫瘍学
  • 生殖医学は,生殖器医学である.

背景:

  • 妊娠期トロフォブラスティック疾患 (GTD) には,前発がん性水性形モールおよび胆がんのような悪性GT腫瘍が含まれます.
  • 歴史的に見て,悪性GTDは高い死亡率を持っていた.

研究 の 目的:

  • GTDの現在の管理戦略を要約する.
  • GTDにおける論争や将来の研究について議論する.

主な方法:

  • GTDの管理とフォローアッププロトコルのレビュー.
  • 治癒率の向上に貢献する要因の分析.

主要な成果:

  • 現在の管理プロトコルは,GTDの98%以上の治癒率を達成しています.
  • 効果的な治療法,バイオマーカーとしてのヒトコリオン性高原素 (hCG),集中ケアが成功の鍵です.

結論:

  • 近代的な管理は,GTDのアウトカムを変えて,高い治癒率と生殖能力の保存を可能にしました.
  • 継続的な研究と集中的なケアが,さらなる進歩のために不可欠です.